Indeed, HS90B has a role in cancer progression, together with proteins including GRP75 and VIME (reported in our Table 1), and as a potential biomarker, useful for diagnostic and therapeutic applications in malignant melanoma cancer [111] or early grade breast cancer [112]. Here, HSPA9 is linked to breast cancer.